Correlation Between Iovance Biotherapeutics and Virpax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Virpax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Virpax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Virpax Pharmaceuticals, you can compare the effects of market volatilities on Iovance Biotherapeutics and Virpax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Virpax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Virpax Pharmaceuticals.
Diversification Opportunities for Iovance Biotherapeutics and Virpax Pharmaceuticals
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Iovance and Virpax is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Virpax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virpax Pharmaceuticals and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Virpax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virpax Pharmaceuticals has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Virpax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Virpax Pharmaceuticals
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.59 times more return on investment than Virpax Pharmaceuticals. However, Iovance Biotherapeutics is 1.69 times less risky than Virpax Pharmaceuticals. It trades about -0.13 of its potential returns per unit of risk. Virpax Pharmaceuticals is currently generating about -0.49 per unit of risk. If you would invest 900.00 in Iovance Biotherapeutics on September 14, 2024 and sell it today you would lose (104.00) from holding Iovance Biotherapeutics or give up 11.56% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Virpax Pharmaceuticals
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Virpax Pharmaceuticals |
Iovance Biotherapeutics and Virpax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Virpax Pharmaceuticals
The main advantage of trading using opposite Iovance Biotherapeutics and Virpax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Virpax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virpax Pharmaceuticals will offset losses from the drop in Virpax Pharmaceuticals' long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Virpax Pharmaceuticals vs. Puma Biotechnology | Virpax Pharmaceuticals vs. Iovance Biotherapeutics | Virpax Pharmaceuticals vs. Sarepta Therapeutics | Virpax Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |